The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Diabetes Supplements-Global Market Insights and Sales Trends 2024
Synopsis
Diabetes, also known diabetes mellitus, is a metabolic disease resulting in high blood sugar. The hormone known as insulin is responsible for the movement of sugar from the blood into the cells, which is stored and used for providing energy to the body. In case of diabetes, body is either unable to produce enough insulin or cannot effectively utilize insulin produced Two main types of diabetes are type 1 diabetes and type 2 diabetes. In case of type 1 diabetes, the immune system attacks and destroys insulin producing cells in the pancreas while in type 2 diabetes patients the body becomes resistant to insulin. Dietary supplements are ingredients that are intended to enhance the diet of a person and contain vitamins, minerals, herbs, amino acids, metabolites, and other substances. These supplements are used for lowering blood glucose, improving cholesterol, lowering blood pressure, neuropathy, insulin resistance, and other complications in diabetic patients.
The global Diabetes Supplements market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Diabetes Supplements in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Diabetes Supplements market. Vitamins, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Minerals segment is estimated at % CAGR for the next seven-year period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diabetes Supplements, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diabetes Supplements market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diabetes Supplements market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diabetes Supplements sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diabetes Supplements covered in this report include Novo Nordisk, Nestlé Health Science, Danone Nutricia, NaturoGain, Nature's Sunshine Forms, Nature's Bounty, Glucose Health, Inc, Unilever(Horlicks Cardia +) and Bionova Lifesciences, etc.
The global Diabetes Supplements market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Nestlé Health Science
Danone Nutricia
NaturoGain
Nature's Sunshine Forms
Nature's Bounty
Glucose Health, Inc
Unilever(Horlicks Cardia +)
Bionova Lifesciences
Caelus Health
Abbott
Pfizer
Arkopharma Laboratories
GlaxoSmithKline
Archer Daniels Midland
Herbalife International
Global Diabetes Supplements market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Supplements market, Segment by Type:
By Supplements Type
Vitamins
Minerals
Herbs
Proteins
Dietary Fibers
Others
By Dosage Form
Tablets
Capsules
Powders
Soft Gels
Liquids
Others
Global Diabetes Supplements market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diabetes Supplements companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Diabetes, also known diabetes mellitus, is a metabolic disease resulting in high blood sugar. The hormone known as insulin is responsible for the movement of sugar from the blood into the cells, which is stored and used for providing energy to the body. In case of diabetes, body is either unable to produce enough insulin or cannot effectively utilize insulin produced Two main types of diabetes are type 1 diabetes and type 2 diabetes. In case of type 1 diabetes, the immune system attacks and destroys insulin producing cells in the pancreas while in type 2 diabetes patients the body becomes resistant to insulin. Dietary supplements are ingredients that are intended to enhance the diet of a person and contain vitamins, minerals, herbs, amino acids, metabolites, and other substances. These supplements are used for lowering blood glucose, improving cholesterol, lowering blood pressure, neuropathy, insulin resistance, and other complications in diabetic patients.
The global Diabetes Supplements market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Diabetes Supplements in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Diabetes Supplements market. Vitamins, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Minerals segment is estimated at % CAGR for the next seven-year period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diabetes Supplements, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diabetes Supplements market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diabetes Supplements market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diabetes Supplements sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diabetes Supplements covered in this report include Novo Nordisk, Nestlé Health Science, Danone Nutricia, NaturoGain, Nature's Sunshine Forms, Nature's Bounty, Glucose Health, Inc, Unilever(Horlicks Cardia +) and Bionova Lifesciences, etc.
The global Diabetes Supplements market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Nestlé Health Science
Danone Nutricia
NaturoGain
Nature's Sunshine Forms
Nature's Bounty
Glucose Health, Inc
Unilever(Horlicks Cardia +)
Bionova Lifesciences
Caelus Health
Abbott
Pfizer
Arkopharma Laboratories
GlaxoSmithKline
Archer Daniels Midland
Herbalife International
Global Diabetes Supplements market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Supplements market, Segment by Type:
By Supplements Type
Vitamins
Minerals
Herbs
Proteins
Dietary Fibers
Others
By Dosage Form
Tablets
Capsules
Powders
Soft Gels
Liquids
Others
Global Diabetes Supplements market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diabetes Supplements companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Diabetes Supplements
1.1 Diabetes Supplements Market Overview
1.1.1 Diabetes Supplements Product Scope
1.1.2 Diabetes Supplements Market Status and Outlook
1.2 Global Diabetes Supplements Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Diabetes Supplements Market Size by Region (2018-2029)
1.4 Global Diabetes Supplements Historic Market Size by Region (2018-2023)
1.5 Global Diabetes Supplements Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Diabetes Supplements Market Size (2018-2029)
1.6.1 North America Diabetes Supplements Market Size (2018-2029)
1.6.2 Europe Diabetes Supplements Market Size (2018-2029)
1.6.3 Asia-Pacific Diabetes Supplements Market Size (2018-2029)
1.6.4 Latin America Diabetes Supplements Market Size (2018-2029)
1.6.5 Middle East & Africa Diabetes Supplements Market Size (2018-2029)
2 Diabetes Supplements Market by Type
2.1 Introduction
2.1.1 Vitamins
2.1.2 Minerals
2.1.3 Herbs
2.1.4 Proteins
2.1.5 Dietary Fibers
2.1.6 Others
2.2 Global Diabetes Supplements Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Diabetes Supplements Historic Market Size by Type (2018-2023)
2.2.2 Global Diabetes Supplements Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Diabetes Supplements Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Diabetes Supplements Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Diabetes Supplements Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Diabetes Supplements Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Diabetes Supplements Revenue Breakdown by Type (2018-2029)
3 Diabetes Supplements Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Diabetes Supplements Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Diabetes Supplements Historic Market Size by Application (2018-2023)
3.2.2 Global Diabetes Supplements Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Diabetes Supplements Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Diabetes Supplements Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Diabetes Supplements Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Diabetes Supplements Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Diabetes Supplements Revenue Breakdown by Application (2018-2029)
4 Diabetes Supplements Competition Analysis by Players
4.1 Global Diabetes Supplements Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Supplements as of 2022)
4.3 Date of Key Players Enter into Diabetes Supplements Market
4.4 Global Top Players Diabetes Supplements Headquarters and Area Served
4.5 Key Players Diabetes Supplements Product Solution and Service
4.6 Competitive Status
4.6.1 Diabetes Supplements Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novo Nordisk
5.1.1 Novo Nordisk Profile
5.1.2 Novo Nordisk Main Business
5.1.3 Novo Nordisk Diabetes Supplements Products, Services and Solutions
5.1.4 Novo Nordisk Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.1.5 Novo Nordisk Recent Developments
5.2 Nestlé Health Science
5.2.1 Nestlé Health Science Profile
5.2.2 Nestlé Health Science Main Business
5.2.3 Nestlé Health Science Diabetes Supplements Products, Services and Solutions
5.2.4 Nestlé Health Science Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.2.5 Nestlé Health Science Recent Developments
5.3 Danone Nutricia
5.3.1 Danone Nutricia Profile
5.3.2 Danone Nutricia Main Business
5.3.3 Danone Nutricia Diabetes Supplements Products, Services and Solutions
5.3.4 Danone Nutricia Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.3.5 NaturoGain Recent Developments
5.4 NaturoGain
5.4.1 NaturoGain Profile
5.4.2 NaturoGain Main Business
5.4.3 NaturoGain Diabetes Supplements Products, Services and Solutions
5.4.4 NaturoGain Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.4.5 NaturoGain Recent Developments
5.5 Nature's Sunshine Forms
5.5.1 Nature's Sunshine Forms Profile
5.5.2 Nature's Sunshine Forms Main Business
5.5.3 Nature's Sunshine Forms Diabetes Supplements Products, Services and Solutions
5.5.4 Nature's Sunshine Forms Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.5.5 Nature's Sunshine Forms Recent Developments
5.6 Nature's Bounty
5.6.1 Nature's Bounty Profile
5.6.2 Nature's Bounty Main Business
5.6.3 Nature's Bounty Diabetes Supplements Products, Services and Solutions
5.6.4 Nature's Bounty Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.6.5 Nature's Bounty Recent Developments
5.7 Glucose Health, Inc
5.7.1 Glucose Health, Inc Profile
5.7.2 Glucose Health, Inc Main Business
5.7.3 Glucose Health, Inc Diabetes Supplements Products, Services and Solutions
5.7.4 Glucose Health, Inc Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.7.5 Glucose Health, Inc Recent Developments
5.8 Unilever(Horlicks Cardia +)
5.8.1 Unilever(Horlicks Cardia +) Profile
5.8.2 Unilever(Horlicks Cardia +) Main Business
5.8.3 Unilever(Horlicks Cardia +) Diabetes Supplements Products, Services and Solutions
5.8.4 Unilever(Horlicks Cardia +) Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.8.5 Unilever(Horlicks Cardia +) Recent Developments
5.9 Bionova Lifesciences
5.9.1 Bionova Lifesciences Profile
5.9.2 Bionova Lifesciences Main Business
5.9.3 Bionova Lifesciences Diabetes Supplements Products, Services and Solutions
5.9.4 Bionova Lifesciences Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.9.5 Bionova Lifesciences Recent Developments
5.10 Caelus Health
5.10.1 Caelus Health Profile
5.10.2 Caelus Health Main Business
5.10.3 Caelus Health Diabetes Supplements Products, Services and Solutions
5.10.4 Caelus Health Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.10.5 Caelus Health Recent Developments
5.11 Abbott
5.11.1 Abbott Profile
5.11.2 Abbott Main Business
5.11.3 Abbott Diabetes Supplements Products, Services and Solutions
5.11.4 Abbott Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.11.5 Abbott Recent Developments
5.12 Pfizer
5.12.1 Pfizer Profile
5.12.2 Pfizer Main Business
5.12.3 Pfizer Diabetes Supplements Products, Services and Solutions
5.12.4 Pfizer Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.12.5 Pfizer Recent Developments
5.13 Arkopharma Laboratories
5.13.1 Arkopharma Laboratories Profile
5.13.2 Arkopharma Laboratories Main Business
5.13.3 Arkopharma Laboratories Diabetes Supplements Products, Services and Solutions
5.13.4 Arkopharma Laboratories Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.13.5 Arkopharma Laboratories Recent Developments
5.14 GlaxoSmithKline
5.14.1 GlaxoSmithKline Profile
5.14.2 GlaxoSmithKline Main Business
5.14.3 GlaxoSmithKline Diabetes Supplements Products, Services and Solutions
5.14.4 GlaxoSmithKline Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.14.5 GlaxoSmithKline Recent Developments
5.15 Archer Daniels Midland
5.15.1 Archer Daniels Midland Profile
5.15.2 Archer Daniels Midland Main Business
5.15.3 Archer Daniels Midland Diabetes Supplements Products, Services and Solutions
5.15.4 Archer Daniels Midland Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.15.5 Archer Daniels Midland Recent Developments
5.16 Herbalife International
5.16.1 Herbalife International Profile
5.16.2 Herbalife International Main Business
5.16.3 Herbalife International Diabetes Supplements Products, Services and Solutions
5.16.4 Herbalife International Diabetes Supplements Revenue (US$ Million) & (2018-2023)
5.16.5 Herbalife International Recent Developments
6 North America
6.1 North America Diabetes Supplements Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Diabetes Supplements Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Supplements Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Diabetes Supplements Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Supplements Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Diabetes Supplements Market Dynamics
11.1 Diabetes Supplements Industry Trends
11.2 Diabetes Supplements Market Drivers
11.3 Diabetes Supplements Market Challenges
11.4 Diabetes Supplements Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
